• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

瑞士2019年新冠疫情期间放射肿瘤学部门的应急计划

Contingency Plans in a Radiation Oncology Department Amid the 2019-nCoV Outbreak in Switzerland.

作者信息

Papachristofilou Alexandros, Finazzi Tobias, Kohler Goetz, Dott Christian, Zimmermann Frank

机构信息

Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland.

出版信息

Adv Radiat Oncol. 2020 Mar 31;5(4):577-581. doi: 10.1016/j.adro.2020.03.012. eCollection 2020 Jul-Aug.

DOI:10.1016/j.adro.2020.03.012
PMID:32363249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7195454/
Abstract

The ongoing novel coronavirus (2019-nCoV) pandemic is expected to develop into an unprecedented stress test for health care systems worldwide. This brief report, written from a radiation oncology perspective during the developing outbreak of 2019-nCoV in Switzerland, highlights the challenges identified and measures taken in our department to mitigate risks and ensure continued operations during the outbreak.

摘要

当前的新型冠状病毒（2019 - nCoV）大流行预计将发展成为对全球医疗保健系统前所未有的压力测试。本简要报告是在瑞士2019 - nCoV疫情爆发期间从放射肿瘤学角度撰写的，重点介绍了我们科室发现的挑战以及为减轻风险和确保疫情期间持续运营所采取的措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa3/7406723/2aeb7d6b4bf7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa3/7406723/2aeb7d6b4bf7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa3/7406723/2aeb7d6b4bf7/gr1.jpg

相似文献

1
Contingency Plans in a Radiation Oncology Department Amid the 2019-nCoV Outbreak in Switzerland.瑞士2019年新冠疫情期间放射肿瘤学部门的应急计划
Adv Radiat Oncol. 2020 Mar 31;5(4):577-581. doi: 10.1016/j.adro.2020.03.012. eCollection 2020 Jul-Aug.
2
Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore.应对 COVID-19 疫情挑战：来自新加坡放射肿瘤服务的观点。
Radiother Oncol. 2020 Jul;148:189-193. doi: 10.1016/j.radonc.2020.03.030. Epub 2020 Mar 31.
3
2019-nCoV: Measures Adopted at the Departments of Oral Surgery and Radiology during the Period of an Uncontrolled Transmission Increase.2019新型冠状病毒：口腔外科与放射科在传播未得到控制期间采取的措施
Dent J (Basel). 2020 Jun 8;8(2):57. doi: 10.3390/dj8020057.
4
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV：流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
5
Response of an oncology unit in the midst of the COVID-19 outbreak.新冠疫情期间一个肿瘤科的应对措施
J Oncol Pharm Pract. 2020 Dec;26(8):1947-1952. doi: 10.1177/1078155220967973. Epub 2020 Oct 22.
6
An update on the 2019-nCoV outbreak.关于 2019-nCoV 爆发的最新情况。
Am J Infect Control. 2020 Jun;48(6):713. doi: 10.1016/j.ajic.2020.01.023. Epub 2020 Mar 12.
7
Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations.2020年中国武汉新型冠状病毒爆发：强化监测对于预防新地点的持续传播至关重要。
J Clin Med. 2020 Feb 11;9(2):498. doi: 10.3390/jcm9020498.
8
Early Prediction of the 2019 Novel Coronavirus Outbreak in the Mainland China Based on Simple Mathematical Model.基于简单数学模型对中国大陆2019年新型冠状病毒疫情的早期预测
IEEE Access. 2020 Mar 9;8:51761-51769. doi: 10.1109/ACCESS.2020.2979599. eCollection 2020.
9
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.2019 新型冠状病毒（2019-nCoV）爆发：新的挑战。
J Glob Antimicrob Resist. 2020 Jun;21:22-27. doi: 10.1016/j.jgar.2020.02.021. Epub 2020 Mar 7.
10
[2019-nCoV: new challenges from coronavirus].[2019新型冠状病毒：冠状病毒带来的新挑战]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):235-238. doi: 10.3760/cma.j.issn.0253-9624.2020.03.002.

引用本文的文献

1
The Top 10 Downloads of 2020 in ASTRO's .美国放射肿瘤学会（ASTRO）2020年十大下载量内容 。
Adv Radiat Oncol. 2021 Jun 17;6(3):100678. doi: 10.1016/j.adro.2021.100678. eCollection 2021 May-Jun.
2
Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing.澳大利亚维多利亚州在应对 COVID-19 第一波和第二波疫情时的放射治疗反应：策略和人员配备。
J Med Imaging Radiat Oncol. 2021 Jun;65(3):374-383. doi: 10.1111/1754-9485.13186. Epub 2021 Apr 27.
3
Impact of the COVID-19 Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution.

本文引用的文献

1
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
2
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.常规分割与大分割高剂量调强放疗治疗前列腺癌：随机、非劣效性3期CHHiP试验的5年结果
Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20.
3
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
新冠疫情高峰对放射治疗的影响：来自纽约地区多中心机构的报告
JCO Oncol Pract. 2021 Sep;17(9):e1270-e1277. doi: 10.1200/OP.20.00619. Epub 2021 Feb 2.
4
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India.在 COVID-19 封锁期间优先提供癌症治疗：印度临床肿瘤学服务的经验。
JCO Glob Oncol. 2021 Jan;7:99-107. doi: 10.1200/GO.20.00433.
5
A multi-institutional assessment of COVID-19-related risk in radiation oncology.一项针对放射肿瘤学中 COVID-19 相关风险的多机构评估。
Radiother Oncol. 2020 Dec;153:296-302. doi: 10.1016/j.radonc.2020.10.013. Epub 2020 Oct 20.
6
Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.COVID-19 大流行期间妇科恶性肿瘤的放射治疗：国际专家共识建议。
Gynecol Oncol. 2020 Aug;158(2):244-253. doi: 10.1016/j.ygyno.2020.06.486. Epub 2020 Jun 15.
7
Evolution of clinical radiotherapy physics practice under COVID-19 constraints.COVID-19 限制下临床放射物理学实践的演变。
Radiother Oncol. 2020 Jul;148:274-278. doi: 10.1016/j.radonc.2020.05.034. Epub 2020 May 29.
8
Mitigating disruptions, and scalability of radiation oncology physics work during the COVID-19 pandemic.减轻新冠肺炎大流行期间放射肿瘤物理学工作的中断和可扩展性。
J Appl Clin Med Phys. 2020 Jul;21(7):187-195. doi: 10.1002/acm2.12896. Epub 2020 May 20.
9
Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic.2019年新型冠状病毒（SARS-CoV-2）疫情期间头颈癌患者的随访与管理
Adv Radiat Oncol. 2020 May 15;5(4):631-636. doi: 10.1016/j.adro.2020.04.031. eCollection 2020 Jul-Aug.
10
Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution.2019年冠状病毒病大流行期间降低接受根治性放疗患者住院率的指南：纽约地区多中心机构报告
Adv Radiat Oncol. 2020 May 11;5(4):621-627. doi: 10.1016/j.adro.2020.04.021. eCollection 2020 Jul-Aug.
调强放射治疗加速部分乳腺照射与全乳照射的比较：一项3期随机对照试验的5年生存分析
Eur J Cancer. 2015 Mar;51(4):451-463. doi: 10.1016/j.ejca.2014.12.013. Epub 2015 Jan 17.
4
Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional.局部晚期宫颈癌的根治性放射治疗：近距离放射治疗不可或缺。
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):537-9. doi: 10.1016/j.ijrobp.2013.11.011. Epub 2014 Jan 7.
5
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.英国乳腺癌放射治疗标准化（START）试验——早期乳腺癌放射治疗的分割方案优化：两项随机对照临床试验的 10 年随访结果。
Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.
6
Hiding in the bunker: Challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreak.躲在掩体中：严重急性呼吸综合征爆发期间放射肿瘤学部门面临的挑战
Australas Radiol. 2003 Jun;47(2):143-5. doi: 10.1046/j.0004-8461.2003.01165.x.